Whoop continues double down on its medical grade ambitions and on Tuesday revealed that it will no longer require a subscription to access its Advanced Labs health monitoring feature.
Instead, the fitness tracking company looks to
“A deeper, earlier understanding of our health gives us a greater ability to shape what comes next,” Dr. Ami Bhatt, chief medical officer at Whoop said. “Whoop Advanced Labs gives people access to comprehensive, clinically reviewed testing that often isn’t part of a routine physical and historically has been available through concierge medicine, executive physicals, or specialty clinics. By making that level of testing more accessible, we’re helping more people better understand their health and make earlier, more informed decisions.”
Advance Labs launched late last year as a way to join a seamless clinical lab testing platform with existing Whoop sourced data to bring in depth health insights to users.
The feature was initially only available to those subscribed to one of the company’s three membership tiers with users being able to upload past bloodwork for analyzation of more than 60 biomarkers.
Meanwhile, Whoop will boost the functionality within Advanced Labs by including the Galleri Test from GRAIL featuring an early detection tool than can screen for over 50 types of cancer. The test utilizes a single blood draw and identifies unique DNA methylation patterns that are exposed by cancer cells.
The test is available at Quest Diagnostics laboratories with around 2,000 locations throughout the United States as all results are later sent to GRAIL’s research facility in North Carolina. Whoop then takes the results which are integrated with existing personal metrics to assist the user how to locate a physical to discuss a treatment plan since the finding are not meant to replace a traditional diagnosis.
“We’re excited to work with Whoop to bring Galleri to a community already highly engaged in understanding, monitoring and improving their health,” Megan Hall, vice president of medical affairs at GRAIL said. “By making multi-cancer early detection available through trusted platforms that are part of people’s everyday health journeys, we can help more people take a proactive step toward finding cancer earlier, when treatment may be more effective.”
Whoop continues its rapidly aggressive push to expand internally and with its product and services offerings this year.
Last week the company confirmed that it would double its footprint in Boston where its headquarters are located and lease 107,000 square feet of office space directly across from its existing location.
It follows a busy July where naming Bhatt was named as Whoop’s chief medical officer, Kyle Leahy hired chief commercial officer, Kristen Moss welcomed as the company’s first chief communications officer and Dirk-Jan “DJ” van Hameren was brought on as chief marketing officer. Yann Gellot was announced as chief accounting officer last Tuesday.
Whoop has placed its valuation at $10 billion after announcing in March that its latest funding round drew $575 million as the push for its long-rumored public offering could take place within the next 18 months.
